Difference between revisions of "Leadership"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Line 12: | Line 12: | ||
[[File:Malini Sathanoori.jpg|center|thumb|Malini Sathanoori, PhD, FACMG, Associate Director, Clinical Cytogenetics, FISH and Microarray Services, PathGroup; '''Associate Editor CCGA [AML Section]''']] | [[File:Malini Sathanoori.jpg|center|thumb|Malini Sathanoori, PhD, FACMG, Associate Director, Clinical Cytogenetics, FISH and Microarray Services, PathGroup; '''Associate Editor CCGA [AML Section]''']] | ||
− | [[File:Church Alanna picture.jpg|center|thumb|Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; ''' | + | [[File:Church Alanna picture.jpg|center|thumb|Alanna Church, MSc, MD, FRCPC, Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Boston Children’s Hospital, Assistant Professor of Pathology, Harvard Medical School; '''Associate Editor CCGA [Gene-Specific Section]''']] |
Revision as of 13:09, 17 March 2021
Meet your editors! We welcome questions and your participation in the CCGA.

Greg Corboy, PhD, Pathology Queensland (Queensland, Australia) School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Hodgkin Lymphomas/Lymphoproliferative Disorders/Other Rare Entities Section]